• Download mobile app
28 Mar 2024, Edition - 3180, Thursday

Trending Now

  • IPL 2024 begins with a bang. First contest between CSK and RCB.
  • Election commission allots mike symbol to Naam Thamizhar Katchi
  • AIADMK promises to urge for AIIMS in Coimbatore, in its election manifesto.
  • Ponmudi becomes higher education minister.

Businesswire

Taro Appoints New Chief Financial Officer

by businesswireindia.com

Share
Business Wire India

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced the appointment of Daphne Huang as Vice President, CFO and Chief Accounting Officer, effective today.

 

Ms. Huang has over 20 years of senior executive experience in finance; most recently serving as Chief Financial Officer at Humanwell Healthcare USA & Puracap International, having financial oversight of their generic pharmaceutical and OTC portfolios.

 

Prior to Humanwell, Ms. Huang held progressively responsible positions in the financial service sector and debt capital markets working for companies such as PriceWaterhouseCoopers, FleetBoston, GE Capital and HSBC.

 

Regarding the appointment, Mr. Uday Baldota, Taro’s CEO, commented, “We are very pleased to have Daphne join the Taro team. Her diversified financial background will further strengthen our management team and contribute to the continuing growth and expansion of our business.”

 

Ms. Huang earned an MBA in Finance and Management from the Leonard N. Stern School of Business at New York University, and a BBA in Accounting from Baruch College.

 

About Taro

 

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

 

 
Source: Businesswire
COIMBATORE WEATHER